These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10740654)

  • 1. Intraarterial HCC therapy with I-131-Lipiodol.
    Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
    Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I-131-Lipiodol therapy in liver neoplasms.
    Risse JH; Grünwald F; Strunk H; Kleinschmidt R; Bender H; Biersack HJ
    Hybridoma; 1999 Feb; 18(1):83-5. PubMed ID: 10211793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
    Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
    Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
    [No Abstract]   [Full Text] [Related]  

  • 4. 18F-FDG-PET and histopathology in 131I-lipiodol treatment for primary liver cancer.
    Risse JH; Pauleit D; Bender H; Rabe C; Fischer HP; Biersack HJ; Bucerius J
    Cancer Biother Radiopharm; 2009 Aug; 24(4):445-52. PubMed ID: 19694579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow.
    de Baere T; Taourel P; Tubiana JM; Kuoch V; Ducreux M; Lumbroso J; Roche AJ
    Radiology; 1999 Sep; 212(3):665-8. PubMed ID: 10478229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohort.
    Risse JH; Rabe C; Pauleit D; Reichmann K; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
    Nuklearmedizin; 2006; 45(4):185-92. PubMed ID: 16964345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
    Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
    Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
    Novell JR; Hilson AJ
    J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
    Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma.
    Raoul JL; Bretagne JF; Bourguet P; Duvauferrier R
    Invest Radiol; 1996 May; 31(5):305-7. PubMed ID: 8724131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131].
    Werenne X
    Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
    Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
    J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of unresectable hepatocellular carcinoma with radiolabelled lipiodol.
    Kanhere HA; Leopardi LN; Fischer L; Kitchener MI; Maddern GJ
    ANZ J Surg; 2008 May; 78(5):371-6. PubMed ID: 18380736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
    Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
    Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
    Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
    J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
    Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
    Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
    Raoul JL; Boucher E; Roland V; Garin E
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.
    Lintia-Gaultier A; Perret C; Ansquer C; Eugène T; Kraeber-Bodéré F; Frampas E
    Nucl Med Commun; 2013 Jul; 34(7):674-81. PubMed ID: 23587835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.